More importantly, recent studies have reported that miR-101 suppressed proliferation and migration of HCC cells by targeting the HGF/c-Met pathway (Liu et al., 2019), PI3K/Akt/mTOR pathway (Zhang et al., 2019) and so on. The gene discussed is MET; the disease is hepatocellular carcinoma.